Cargando…
One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia
BACKGROUND: This is the first report of the 1-year outcomes of the EVEREST-I study evaluating the safety and efficacy of the Optilume(®) BPH Catheter System, a prostatic paclitaxel-coated balloon catheter system, for the treatment of lower urinary tract symptoms (LUTS) related to benign prostatic hy...
Autores principales: | Kaplan, Steven A., Pichardo, Merycarla, Rijo, Edwin, Espino, Gustavo, Lay, Ramon Rodriguez, Estrella, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616755/ https://www.ncbi.nlm.nih.gov/pubmed/33833379 http://dx.doi.org/10.1038/s41391-021-00362-z |
Ejemplares similares
-
Correction: One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia
por: Kaplan, Steven A., et al.
Publicado: (2021) -
A Drug-Coated Balloon Treatment for Urethral Stricture Disease: Three-Year Results from the ROBUST I Study
por: Virasoro, Ramón, et al.
Publicado: (2022) -
The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms
por: Yu, Seong Hyeon, et al.
Publicado: (2022) -
Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm(®) system: evaluation of acute ablative capabilities in the human prostate
por: Dixon, Christopher M, et al.
Publicado: (2015) -
The Urinary Tract Microbiome in Male Genitourinary Diseases: Focusing on Benign Prostate Hyperplasia and Lower Urinary Tract Symptoms
por: Kim, Myung Soo, et al.
Publicado: (2021)